Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:OCUL News 6 December 2025 - 9 December 2025

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

All figures and opinions reflect information available on December 9, 2025 and may change over time. This article is for informational purposes only and is not investment advice. OCUL Stock Today: A 52‑Week High After a Single Press Release Ocular Therapeutix, Inc. (NASDAQ: OCUL) has suddenly moved from sleepy mid-cap biotech to front-page ticker. On Monday, December 8, the stock closed at $16.11, up 28.1% on the day, after trading as high as $16.44 and setting a new 52‑week high. The prior close was $12.58, meaning the name has rallied sharply over just a few sessions.FinancialContent+1 Year to date, OCUL
9 December 2025
Ocular Therapeutix (OCUL) Stock News Today: Price, Forecast and Analysis as AXPAXLI NDA Plan Emerges

Ocular Therapeutix (OCUL) Stock News Today: Price, Forecast and Analysis as AXPAXLI NDA Plan Emerges

As of the close on Friday, December 5, 2025, Ocular Therapeutix, Inc. (NASDAQ: OCUL) finished regular trading at $12.58 per share, up about 1.2% on the day, with after‑hours quotes on some platforms briefly touching the $14 area. StockAnalysis+1 The move caps a strong week: on Thursday the stock jumped roughly 12.3% to around $12.87, well above its recent averages, as traders responded to a new regulatory strategy for its lead retina drug AXPAXLI and fresh analyst commentary. MarketBeat+1 At the same time, OCUL remains firmly in “story stock” biotech territory: still loss‑making, heavily dependent on its late‑stage pipeline, but
6 December 2025
···

Stock Market Today

SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

7 February 2026
SAP SE closed at 171.22 euros on Xetra Friday, up 0.43%, after disclosing its treasury shares rose above 5% of capital, reaching 61,737,035 shares. The increase follows the launch of a buyback plan worth up to 2.6 billion euros through July 2026. SAP’s U.S. shares finished at $203.34. Investors await SAP’s Integrated Report on Feb. 26 and next results on April 23.
Go toTop